Healthcare startup ekincare raises over Rs 25 crore in Series A funding Farhat Nasim14 Nov 2019 10:10 AM ISTNew Delhi: Health benefits start-up ekincare on Wednesday said it has raised USD 3.6 million (about 25.8 crores) in a funding round from investors...
Eli Lilly-Boehringer diabetes drug Empagliflozin gets thumbs down from FDA panel Medical Dialogues Bureau14 Nov 2019 9:45 AM ISTEmpagliflozin belongs to a class of drugs called SGLT2 inhibitors, like Johnson & Johnson's Invokana and AstraZeneca Plc's Farxiga, which lower...
Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore Medical Dialogues Bureau14 Nov 2019 9:30 AM ISTManaging director of Aurobindo Pharma N Govindarajan said We had another quarter of healthy performance where we continued to grow in the US and...
Merck licenses CRISPR gene-editing technology to Evotec Farhat Nasim14 Nov 2019 9:15 AM ISTNew Delhi: Merck, recently announced that it has signed a license agreement providing Evotec SE access to Merck's foundational CRISPR intellectual...
Mediation between Bayer, plaintiffs seeks to clarify all justified claims: US mediator Medical Dialogues Bureau14 Nov 2019 9:00 AM ISTBayer is trying to reach a settlement after earlier court rulings against it. The German drugs and pesticides maker, which acquired Roundup and other...
NPPA fixes retail price of 14 drug formulations; Details Farhat Nasim13 Nov 2019 11:23 AM ISTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
Bristol-Myers Opdivo, Yervoy combination gets USFDA priority review for advanced HCC Medical Dialogues Bureau13 Nov 2019 10:00 AM ISTNew Delhi: Bristol-Myers Squibb Company recently announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics...
JnJ blockbuster drug Remicade losing ground in Quebec health plan despite court victory Farhat Nasim13 Nov 2019 9:47 AM ISTThe plan's administrator stopped covering Remicade, JnJ unit Janssen's version of the drug infliximab, for some new patients in February 2017, in...
Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US Medical Dialogues Bureau13 Nov 2019 9:33 AM IST"The decline in revenues and profits compared to the same period last year is primarily due to the anticipated drop in oseltamivir product sales in...
Owlstone Medical collaborates with Thermo Fisher Scientific to advance use of breath samples to detect disease Medical Dialogues Bureau13 Nov 2019 9:32 AM ISTCambridge: Owlstone Medical, recently announced it has partnered with Thermo Fisher Scientific. The collaboration seeks to advance the application of...
Changsheng Life Sciences declared bankrupt in vaccine scandal Medical Dialogues Bureau13 Nov 2019 9:00 AM ISTChangsheng Life Sciences used expired materials, mixed different batches of products and failed to test them properly, according to regulators. They...
Lupin to sell Japanese arm Kyowa Pharma to Unison for Rs 3702 crore Medical Dialogues Bureau12 Nov 2019 4:46 PM ISTAs per a recent release by Lupin, the proposed transaction values Kyowa at an enterprise value of JPY 57,361 million (~INR 37,024 million) and will...
